(Reuters Health) - For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study.
* Analysts question Biogen's growth prospects
(Adds context, details, background)
(Reuters Health) - Young women are largely unaware of the risks they face from cardiovascular disease, even though it remains the top cause of death for American women, researchers warn.
Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results that had been scheduled to be presented on Sunday.
Bristol-Myers Squibb defended its planned $74 billion takeover of Celgene Corp, saying it had carried out a "robust" assessment of the merger after two major investors opposed what could be the largest pharmaceutical deal ever.
(Reuters Health) - Men who have smoked marijuana may be more fertile than those who've never touched a joint, new data suggest, surprising researchers who had expected the opposite.
U.S. health spending is expected to grow at an average rate of 5.5 percent every year from 2018 over the next decade and will reach nearly $6 trillion by 2027 as more people become eligible for Medicare, a government health agency said on Wednesday.
(Reuters Health) - More babies could be born with heart defects in the future as global warming puts pregnant women at greater risk of exposure to dangerously high temperatures, new research suggests.
(Reuters Health) - Certain tumors labeled as "cancer" aren't life-threatening and should be called something else instead, some doctors believe.
Eli Lilly and Co on Wednesday embraced a U.S. government proposal to end a decades-old system of rebates drugmakers make to industry middlemen, saying it could lower the cost of insulin and other prescription drugs for patients.